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Abstract
Hsp90 is a ubiquitous molecular chaperone responsible for assembly and regulation of many 
eukaryotic signalling systems, and an emerging target for rational chemotherapy of many cancers. 
Although the structures of isolated domains of Hsp90 have been determined, the arrangement and 
ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious. Here 
we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analogue and 
the co-chaperone p23/Sba1. The structure reveals the complex architecture of the ‘ closed’  state of 
the Hsp90 chaperone, the extensive inter-domain and inter-strand interactions, the detailed 
conformational changes in the N-terminal domain that accompany ATP binding, and the structural 
basis for stabilisation of the closed state by p23/Sba1. Contrary to expectations, the closed Hsp90 
would not enclose its client proteins but provides a bipartite binding surface whose formation and 
disruption is coupled to the chaperone ATPase cycle.
Hsp90 is an essential molecular chaperone in eukaryotes, required for activation of many 
regulatory and signalling ‘ client’  proteins. Hsp90 function depends on its ability to bind and 
hydrolyse ATP1, 2, and pharmacological inhibition by ATP-competitors promotes client 
degradation3, 4. The requirement of Hsp90 for the function of oncogenic protein kinases 
such as ErbB2, Cdk4, B-Raf, Akt/PKB etc (reviewed in5) makes it an attractive target for 
novel cancer therapeutics6. Hsp90 associates with a plethora of co-chaperones, several of 
which regulate progress through its ATPase cycle7–9. The p23 co-chaperone and its 
S.cerevisiae homologue Sba1, preferentially bind Hsp90 in the presence of ATP or ATP-
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mimetics10–12. As p23/Sba1 binds ~70-fold more tightly to ATP-bound Hsp90{Siligardi, 
2004 #658}, it stabilises the state required for client-protein activation, slowing ATP 
turnover7, 13, 14. This regulatory property explains why, although not essential for Hsp90-
dependent activation of client proteins, p23/Sba1 makes it more efficient15, 16.
Previous studies suggested that the dimeric Hsp90 operates a ‘ molecular clamp’  mechanism 
coupled to its ATPase cycle, involving closure of a ‘ lid’  segment and transient dimerisation 
of the N-terminal nucleotide-binding domain in the ATP-bound state17, 18. However, this 
model has recently been challenged19–21. We have now determined the crystal structure of 
yeast Hsp90 trapped in a closed conformation, in complex with a non-hydrolysable ATP 
analogue and p23/Sba1. The structure provides a first view of Hsp90 in the ATP-bound state, 
defining the conformational changes in the N-domain that accompany closure, and revealing 
how p23/Sba1 recognises and stabilises the ATP-bound conformation of the Hsp90 dimer. 
The structure confirms the ATPase coupled molecular clamp mechanism, and provides a 
structural basis from which to understand ATP-dependent activation of Hsp90 client 
proteins.
Architecture of the Hsp90-p23/Sba1 Complex
Yeast Hsp90, with an Ala107Asn mutation shown to activate Hsp90s ATPase cycle18, and 
with truncation of the dispensable charged-linker connecting the N-domain and middle 
segments22, was co-crystallised with the non-hydrolysable ATP analogue AMP-PNP and 
Sba1, the yeast homologue of p2311. Crystals were phased by molecular replacement with 
the isolated N-terminal domain23 and middle segment of yeast Hsp9024, and the globular 
core of human p2325. The structure of the yeast Hsp90 C-terminal domain was determined 
independently from crystals of a middle-and C-terminal Hsp90 construct (M-C) consisting 
of residues 273-709 refined at 3.0Å, and completed the molecular replacement solution, 
allowing refinement of the full ~ 220 kDa (Hsp90)2 - (Sba1)2 complex against anisotropic 
data to a maximum resolution of 3.1Å (3.5Å isotropic) (see Supplementary Information).
The Hsp90-p23/Sba1 complex contains a central Hsp90 dimer with symmetrically disposed 
p23/Sba1 molecules on either side (Figure 1a,b,c,d). The Hsp90 protomers have a parallel 
arrangement, with domains arranged in linear order such that the N-terminal domains are at 
one end of the dimer, and the C-terminal domains at the other. The protomers have a left-
handed helical twist around the long axis of the dimer. Each Hsp90 protomer consists of four 
domains (Figure 1e). The N-domain (residues 1-216) is a two-layer sandwich, formed by a 
twisted ?-sheet on one face, and a cluster of ?-helices on the other, delimiting the binding 
pocket for ATP and a range of inhibitors26–30. The N-domain connects to the middle 
segment via an antiparallel ?-strand involving residues 206-213 and 262-269. The loop 
connecting these strands formed by the truncated charged-linker, is disordered.
The middle segment consists of a large three-layer ?-?-? domain (residues 273-409) 
connected to a small ?-?-? domain (435-525) via a helical coil (411-443)24. The relative 
orientation of the large and small domains is little changed from the isolated middle segment 
structure. An amphipathic loop (residues 329-339) implicated in client protein 
interactions24, projects from the inner face of the larger domain towards its equivalent in the 
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other monomer. An extended loop connects the middle segment to the beginning of a curved 
?-helix (534-559) at the start of the C-domain, which consists of a three stranded ?-sheet, 
packed beneath the curved helix and capping one face of a three-helix coil, whose other face 
forms the constitutive dimerisation interface. A helix-strand segment (residues 587-610) 
projects from the core of the C-domain towards the N-terminal end of the dimer and is 
involved in dimeric interactions with its equivalent in the other protomer. The yeast C-
domain is similar in structure to the E.coli HtpG C-domain31, but with a significantly 
different orientation for this projecting helix-strand segment. Residues 678-709, which 
provide the C-terminal EEVD binding sequence for TPR-domain co-chaperones32, are 
disordered.
Sba1 has the same two-layer ?-sandwich structure as human p2325, with some differences 
in the loops connecting the ?-strands. Unlike unbound p23, ordered structure is evident 
beyond the core, with a segment of the charged C-terminal tail (residues 129-139) snaking 
up towards the middle of the complex.
Domain Interactions and Conformational Changes
Extensive interfaces occur between the domains of the two Hsp90s, and the p23/Sba1 
molecules. The constitutive dimerisation interface between the C-domains is essentially 
identical in the M-C structure (residues 273-709) and the full complex, suggesting little 
change on ATP-binding. The interface between the C-domain and small middle segment 
domain, flexes on going from the unconstrained M-C structure to the ATP-bound 
conformation, bringing the small middle domains ~10Å closer together. This displaces the 
projecting helix-strand segments, which tilt downwards and become less well ordered. As 
several temperature sensitive mutations of yeast Hsp90 map in this regions33, 34, this 
conformational change may have functional significance. The middle segment large domains 
move even more in the ATP-bound conformation, coming ~20Å closer together. Although 
the middle segments do not actually come into contact, the gap remaining between them is 
too small to accommodate a folded client protein (Figure 2a).
As previously shown17, 18, and in contradiction to recent suggestions19–21 the N-domains 
form an intimate dimeric interaction, involving significant changes in conformation relative 
to their structure in isolation. Firstly, the N-terminal ?-strand (residues 1-9) swaps over to 
hydrogen bond to the edge of the main ?-sheet in the N-domain of the other monomer, with 
concomitant movement of the first ?-helix (residues 13-22) – an arrangement also seen in 
dimers of MutL and GyrB35, 36 (Figure 2b). Secondly, the ‘ lid’  segment (residues 94-125), 
swings through nearly 180° from its ‘ open’  position in the isolated N-domain, hinged at Gly 
94 and Gly121, to fold over the nucleotide-binding pocket. The lid movement exposes a 
hydrophobic patch centred on Leu15 and Leu18, which along with Gln 14, and Thr 95, Ile 
96, Ala 97 and Phe 120 from the hinge-points of the lid, form a substantial interface with 
their equivalents in the other monomer. Thus, as we previously suggested, lid closure in the 
ATP-bound state reveals a hydrophobic patch whose burial stabilises N-domain 
association18. The lid movement explains the effects of Thr101Ile and Ala107Asn 
mutations. Thr101 is buried in the open conformation of the lid, becoming exposed in the 
ATP-bound complex; its mutation to the more hydrophobic isoleucine stabilises the open 
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conformation, decreasing ATPase activity. Ala107 comes close to Tyr 47 in the closed 
conformation; mutation to asparagine allows a polar interaction with Tyr47, stabilising the 
closed conformation and enhancing ATPase activity (Figure 2c).
While the middle segments move together, they do not make contact. However each one 
interacts with the N-domain of the other protomer, in addition to the interface with its own 
N-domain (see below). This inter-molecular inter-domain interface involves Thr22, Val23 
and Tyr24 from the N-domain, in a hydrophobic interaction with Leu376 and Leu378 in the 
middle segment loop bearing the catalytic residue Arg380. The involvement of Thr22 in this 
interface is particularly interesting, as Thr22Ile had been isolated as a ts allele in vivo34 and 
activated Hsp90s ATPase in vitro18, although the mechanism of this was not clear. Mutation 
to the more hydrophobic isoleucine would reinforce the interface with the catalytic loop, 
stabilising its active conformation (Figure 3a).
Nucleotide Interactions and active site formation
The adenine, ribose and ? and ? phosphate groups of AMP-PNP occupy the same position 
as ADP in high-resolution studies of the isolated N-terminal domain26, 2. The ?-phosphate 
is cradled in a glycine-rich loop at the C-terminal hinge of the lid, hydrogen bonding with 
the peptide backbone of Gln119, Gly121, Val122 and Gly123. The ?-phosphate hydrogen 
bonds with the peptides of Phe 124, and Gly100 from the N-terminal hinge (Figure 3b).
The nucleotide makes a single contact outside the N-domain – a polar interaction between 
its ?-phosphate and the head group of Arg380, which projects into the nucleotide-binding 
pocket from the middle segment, close to the catalytically essential Glu331. The N-domain 
makes extensive interactions with the middle segment of the same protomer, involving the 
side chain of Phe200 from the N-domain, packing into a hydrophobic pocket formed by 
Thr273, Pro275, Trp277, Phe292 and Tyr344 in the middle segment. Residues 114-120 from 
the lid in the N-domain make polar and hydrophobic interactions with residues 372-379 
from the middle segment catalytic loop. Both these segments have very different 
conformations in the isolated domains, so that their conformations in the ATP-bound 
complex are mutually interdependent (Figure 3a).
Previous studies suggested close interactions between the N-domain and middle segment of 
the protein in the ATP-bound state, and identified Arg380 as an essential catalytic residue 
37, 24. The juxtaposition of the N-domain and middle segments, and the proximity of 
Arg380 to the bound nucleotide in the structure presented here, completely vindicate that 
mechanistic proposal. However, involvement of Arg380 has recently been questioned on the 
basis of structures of the E.coli Hsp90 HtpG, lacking the C-terminal dimerisation domain 
(residues 1-559), and in the presence of ADP19. These structures show radically different 
conformations to the present study, with little contact between the middle segment and the 
nucleotide-binding pocket, and with the equivalent of Arg380 too far from the nucleotide to 
play a catalytic role. While the bacterial homologue could operate by a different mechanism, 
the strong conservation of the residues involved in the N-domain - middle segment interface, 
and the sequence identity of almost all residues involved in nucleotide interactions, make 
this highly improbable. Most likely the HtpG conformation is an artefact, stabilised by 
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favourable crystal lattice contacts, and reflecting the considerable flexibility of the protein in 
the ATP-free state.
Structural basis for conformation-dependent recruitment of p23/Sba1
Each p23/Sba1 molecule lies in a depression at the junction of the two Hsp90 N-domains, 
contacting each via distinct surface patches (Figure 4a). The smaller interface involves 
residues 31-37 and 85-91 at the tips of ?-hairpins in p23/Sba1 and residues 12-21 and 
151-155 from one Hsp90 N-domain. The larger interface involves residues 13-16 from the 
N-terminal strand of p23/Sba1 along with a broad loop formed by residues 113-118, which 
packs against the surface of the lid segment of the other N-domain (Figure 4b). Formation of 
this interface requires lid closure, so that binding of p23/Sba1 would stabilise the ATP-
bound conformation. Consistent with this, mutation of Ile117 in this loop causes significant 
loss of Sba1 function in vivo38.
A third interface involves residues 120-125 of p23/Sba1 binding across the inter-molecular 
inter-domain junction (see above). One side of this bridging interaction involves Lys27 and 
Lys387 of Hsp90, and Asp122 and the peptide carbonyls of Phe121, Asp122 and Trp124, of 
p23/Sba1. On the other side, Phe121 and Trp124 from p23/Sba1 pack into a hydrophobic 
recess formed by Leu315, Pro375, Ile388 and Val391 from Hsp90 (Figure 4c). Remarkably, 
Lys387, Ile388 and Val391 from the catalytic loop make very similar interactions with 
Aha137, an Hsp90 co-chaperone that significantly activates Hsp90s inherent 
ATPase{Panaretou, 2002 #520; Lotz, 2003 #579; Siligardi, 2004 #658} (Figure 4d). Binding 
of Aha1 to Hsp90 remodels the catalytic loop towards the conformation seen in the AMP-
PNP - bound Hsp90-p23/Sba1 complex. Although unrelated, Aha1 and p23/Sba1 share an 
ability to stabilise the catalytic loop in an active conformation, promoting ATP-hydrolysis. 
However, with a common binding site, their interaction with Hsp90 is mutually exclusive39.
None of the Hsp90 - p23/Sba1 interfaces have significant affinity individually, but in 
combination add to a substantial degree of interaction. However the p23/Sba1 binding sites 
are only presented in the correct three-dimensional configuration when Hsp90 is in the ATP-
bound state. Thus, p23/Sba1 recruitment is ATP dependent, but once bound provides a 
scaffold, reinforcing the ATP-bound conformation and extending the lifetime of the state of 
the chaperone required for client protein activation.
ATPase coupled conformational cycle and client-protein activation
The structure presented here defines the ‘ tense’  state of the chaperone and confirms the 
proposed dimerisation-coupled ‘ split’  ATPase mechanism 18, 17, uniting Hsp90 with other 
dimeric GHKL ATPases, such as MutL and GyrB35, 36. As the key residues involved are 
highly conserved between yeast and human Hsp90s, it is difficult to rationalise suggestions 
that human Hsp90 has a different mechanism21. Hsp90 in solution does not have a single 
‘ relaxed’  conformation, but exists as a continuum of C-terminally dimerised conformations 
in which the rest of the molecule is unconstrained40. The ATP-bound state by contrast is a 
highly constrained structure whose formation involves coupled conformational switches in 
the N-terminus and lid of the N-domain, and in the catalytic loop of the middle segment, 
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which together position the two halves of the catalytic apparatus for ATP hydrolysis. These 
switches rather than ATP hydrolysis itself, govern the rate of the chaperone cycle, and 
mutations that affect them alter Hsp90 ATPase activity in vitro and client protein activation 
in vivo33, 34, 18, 41. Furthermore, Hsp90 co-chaperones such as p23/Sba1, Aha1 and 
Cdc37, that regulate the chaperone ATPase cycle, do so by interacting with these switch 
components{Meyer, 2004 #619; Roe, 2004 #618; Siligardi, 2004 #658}.
Mutational analysis 1, 2, and the effect of ATP-competitive inhibitors6, show that ATP-
binding to Hsp90 is crucial for client protein activation in vivo. Now the structural 
consequences of ATP binding to Hsp90 are understood, the key question remains – what 
property of this conformation contributes to client protein activation. At least for protein 
kinases some insight comes from an EM reconstruction of an Hsp90-Cdc37-Cdk4 complex 
(C.K. Vaughan, U.Gohlke, F. Sobott, V.M. Good, M.M.U. Ali, C. Prodromou, C.V. 
Robinson, H.R. Saibil, L.H. Pearl, manuscript submitted). This suggests that the two lobes 
of the kinase interact with different domains of Hsp90, so that the client conformation is 
directly coupled to the changes in their relative position that accompany the chaperone 
ATPase cycle. While this may provide a general mechanism for coupling chaperone and 
client conformations, how such changes in a client facilitate its activation remains to be 
defined. The structural data presented here provide a firm basis from which this key 
mechanistic question can be addressed.
Methods Overview
A full-length construct of yeast Hsp90 harbouring the mutation A107N and with residues 
221-255 in the charged linker region deleted and replaced by LQHMASVD; an N-terminal 
and middle-segment (M-C) construct of yeast Hsp90 (residues 273-709); and full-length 
yeast p23 (Sba1) were inserted with addition of N-terminal His6-tag and PreScission 
protease cleavage site into pRSETA, and expressed in E.coli BL21(DE3) pLysS. The 
expressed proteins were purified to homogeneity by column chromatography and used in 
crystallisation experiments.
Crystals of the Hsp90-p23/Sba1 AMP-PNP complex and of the M-C construct were grown 
in hanging-drop vapour diffusion experiments, snap-frozen in liquid nitrogen, and used to 
collect X-ray diffraction data at ESRF Grenoble. The M-C structure was solved by 
molecular replacement with the yeast middle segment structure, and the C-terminal domain 
built from difference Fourier maps. The complex structure was determined by molecular 
replacement with structures of the separate N- middle and C-domains of yeast Hsp90, and 
human p23. Structures were refined using automated procedures interspersed with manual 
rebuilding.
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Figure 1. Architecture of Hsp90-p23/Sba1 Complex
a) Backbone tracing of the (Hsp90)2-(p23/Sba1)2 complex; Hsp90 - blue and orange, p23/
Sba1 - red and green. All molecular graphics were produced with MacPyMOL 
(www.pymol.org)
b) Molecular surface equivalent of a). The left-handed twist of the Hsp90 molecules is 
evident.
c) As b) the projecting ?-ribbon is connected by the truncated charged-linker, which is 
disordered in the crystals.
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d) As c) but rotated by 90° around the horizontal so that the exchange of the N-terminal 
strands is evident.
e) Orthogonal view of Hsp90 protomer, rainbow coloured from the N-terminus (blue) to the 
C-terminus (red).
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Figure 2. ATP-Dependent Conformational Changes
a) Comparison of the dimerised M-C construct (left), and equivalent regions from the 
Hsp90-p23/Sba1 complex (right). ATP-dependent association of the N-domains brings the 
the middle segments ~20Å closer together. The central ‘ thumbnail’  of the Hsp90 dimer 
shows the direction of view and location of the M-C region in the overall structure.
b) Secondary structure cartoon of the strand-swapped interface between the N-domains of 
Hsp90, viewed from the base (left) and side (right).
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c) Comparison of the isolated N-domain (left), and the AMP-PNP-bound state (right). In 
addition to lid closure, there is considerable movement of the N-terminal helix and complete 
detachment of the N-terminal strand, which swaps into the other N-domain of the dimer 
(shown as a ghost).
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Figure 3. Domain Interfaces and Active Site Formation
a) Interfaces between the Hsp90 N-domains and middle segments: the inter-molecular N-
domain (pale blue background), inter-molecular N-domain – middle (pale pink), and intra-
molecular N-domain – middle segment (pale yellow) that assembles the catalytic apparatus.
b) Details of the split catalytic apparatus. The ?-phosphate of AMP-PNP is orientated for 
attack by a water activated by Glu33. Arg380 polarises the ?-? phosphodiester bond and 
neutralises the transition state. Mutation of Glu33 or Arg380 kills catalysis; mutation of 
Asp79 abolishes ATP binding 24, 1. The mesh shows Fo-Fc ‘ omit’  electron-density for the 
catalytic loop (red) and ATP-analogue (orange).
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Figure 4. Mechanism of ATPase Regulation by p23/Sba1
a) Overall view of one p23/Sba1 molecule (green) packed against the Hsp90 dimer (cyan 
and orange), and interacting with the ‘ lid’  (yellow) in its ATP-dependent closed 
conformation. Details are shown in b) and c).
b) Residues 113-118 of p23/Sba1 (green) pack onto the ‘ lid’  (orange). Mutation of Ile117 
causes severe Sba1 loss of function in yeast38.
c) The conserved DFxxW motif of p23/Sba1 binds across the inter-molecular inter-domain 
interface, reinforcing the activated conformation of the catalytic loop carrying Arg380.
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d) Binding sites for p23/Sba1 (left) and Aha1 (right) overlap, so that their recruitment to 
Hsp90 is mutually exclusive39.
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